Invention Grant
- Patent Title: Tumor antigen based on products of the tumor suppressor gene WT1
- Patent Title (中): 基于肿瘤抑制基因WT1产物的肿瘤抗原
-
Application No.: US12366200Application Date: 2009-02-05
-
Publication No.: US07807792B2Publication Date: 2010-10-05
- Inventor: Haruo Sugiyama , Yoshihiro Oka
- Applicant: Haruo Sugiyama , Yoshihiro Oka
- Applicant Address: JP Suita-shi
- Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee: International Institute of Cancer Immunology, Inc.
- Current Assignee Address: JP Suita-shi
- Agency: Oblon, Spivak, McClelland, Maier & Neustadt, L.L.P.
- Priority: JP10-218093 19980731
- Main IPC: C07K16/00
- IPC: C07K16/00
Abstract:
A tumor antigen that comprises, as an active ingredient, a product of the Wilms' tumor suppressor gene WT1 or a peptide composed of 7-30 contiguous amino acids containing an anchor amino acid for binding to major histocompatibility complex (MHC) class I in said amino acid sequence, and a vaccine comprising said antigen.
Public/Granted literature
- US20090281043A1 TUMOR ANTIGEN BASED ON PRODUCTS OF THE TUMOR SUPPRESSOR GENE WT1 Public/Granted day:2009-11-12
Information query
